, annual) metrics reports for infection control websites using available digital analytics, including Adobe Analytics, Foresee... ASCI data, Google Search Console, and other available analytics and usability tools as appropriate. Generate specific...
and Analytics team .We are seeking a Principal Data Engineer – data engineering to build high quality, scalable and resilient... distributed systems that power Medtronic Diabetes analytics platform and data pipelines. As a Principal Data Engineer – data...
-throughs, data analytics, observation, and reperformance. Safeguards assets by monitoring corporate activity. Performs SOX..., Accounting Information Systems, Data Analytics, Internal Auditing, Business Information Technology, Accounting Licenses...
growth strategies Provide actionable recommendations based on data-driven findings Collaborate with Data and Analytics... team to integrate cutting-edge analytics into financial decision making Utilize SQL databases, Power BI or Tableau...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »